Profil
Heather DiBenedetto formerly worked at Millennium Pharmaceuticals, Inc., as Director-Oncology Clinical Operations from 2007 to 2010, Moderna, Inc., as Head-Therapeutic Operations from 2016 to 2020, and Tango Therapeutics, Inc., as Chief Development Operations Officer from 2020 to 2026.
Ms. DiBenedetto received her graduate degree from Massachusetts College of Pharmacy & Health Science and undergraduate degree from the University of Vermont.
Ehemalige bekannte Positionen von Heather DiBenedetto
| Unternehmen | Position | Ende |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Corporate Officer/Principal | 01.06.2026 |
| MODERNA, INC. | Corporate Officer/Principal | 01.01.2020 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01.01.2010 |
Ausbildung von Heather DiBenedetto
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Massachusetts College of Pharmacy & Health Science
Massachusetts College of Pharmacy & Health Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vermont
University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moderna, Inc.
Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Tango Therapeutics, Inc.
Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
















